{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:50:03Z","timestamp":1791078603416,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T00:00:00Z","timestamp":1342742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00018-012-1083-5","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T12:02:13Z","timestamp":1342699333000},"page":"4191-4204","source":"Crossref","is-referenced-by-count":24,"title":["Replacement of huntingtin exon 1 by trans-splicing"],"prefix":"10.1007","volume":"69","author":[{"given":"Hansj\u00f6rg","family":"Rindt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Fen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina N.","family":"Thebeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy S.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,20]]},"reference":[{"key":"1083_CR1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"1083_CR2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J, Floresco SB, O\u2019Kusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR (1995) Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81:811\u2013823","journal-title":"Cell"},{"key":"1083_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat Genet 11:155\u2013163","journal-title":"Nat Genet"},{"key":"1083_CR4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, Ge P, Vonsattel JP, Gusella JF, Joyner AL et al (1995) Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269:407\u2013410","journal-title":"Science"},{"key":"1083_CR5","doi-asserted-by":"crossref","unstructured":"MacDonald ME (2003) Huntingtin: alive and well and working in middle management. Sci STKE 207:pe48","DOI":"10.1126\/stke.2003.207.pe48"},{"key":"1083_CR6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"SH Li","year":"2004","unstructured":"Li SH, Li XJ (2004) Huntingtin-protein interactions and the pathogenesis of Huntington\u2019s disease. Trends Genet 20:146\u2013154","journal-title":"Trends Genet"},{"key":"1083_CR7","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1523\/JNEUROSCI.17-09-03052.1997","volume":"17","author":"RJ Ferrante","year":"1997","unstructured":"Ferrante RJ, Gutekunst CA, Persichetti F, McNeil SM, Kowall NW, Gusella JF, MacDonald ME, Beal MF, Hersch SM (1997) Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J Neurosci 17:3052\u20133063","journal-title":"J Neurosci"},{"key":"1083_CR8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","volume":"19","author":"FR Fusco","year":"1999","unstructured":"Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, Surmeier DJ, Honig MG, Carlock LR, Reiner A (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington\u2019s disease. J Neurosci 19:1189\u20131202","journal-title":"J Neurosci"},{"key":"1083_CR9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","volume":"14","author":"M DiFiglia","year":"1995","unstructured":"DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel JP, Carraway R, Reeves SA et al (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14:1075\u20131081","journal-title":"Neuron"},{"key":"1083_CR10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/exnr.1998.6832","volume":"152","author":"J Velier","year":"1998","unstructured":"Velier J, Kim M, Schwarz C, Kim TW, Sapp E, Chase K, Aronin N, DiFiglia M (1998) Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp Neurol 152:34\u201340","journal-title":"Exp Neurol"},{"key":"1083_CR11","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","volume":"277","author":"KB Kegel","year":"2002","unstructured":"Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle E, Cuiffo BG, Sapp E, Wang Y, Qin ZH, Chen JD, Nevins JR, Aronin N, DiFiglia M (2002) Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem 277:7466\u20137476","journal-title":"J Biol Chem"},{"key":"1083_CR12","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayan J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, Wiktorski S, Hodes ME, Conneally PM, Penney JB, Gusella J, Cha JH, Irizarry M, Rosas D, Hersch S, Hollingsworth Z, MacDonald M, Young AB, Andresen JM, Housman DE, De Young MM, Bonilla E, Stillings T, Negrette A, Snodgrass SR, Martinez-Jaurrieta MD, Ramos-Arroyo MA, Bickham J, Ramos JS, Marshall F, Shoulson I, Rey GJ, Feigin A, Arnheim N, Acevedo-Cruz A, Acosta L, Alvir J, Fischbeck K, Thompson LM, Young A, Dure L, O\u2019Brien CJ, Paulsen J, Brickman A, Krch D, Peery S, Hogarth P, Higgins DS Jr, Landwehrmeyer B (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci USA 101:3498\u20133503","journal-title":"Proc Natl Acad Sci USA"},{"key":"1083_CR13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"1083_CR14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","volume":"23","author":"JH Cha","year":"2000","unstructured":"Cha JH (2000) Transcriptional dysregulation in Huntington\u2019s disease. Trends Neurosci 23:387\u2013392","journal-title":"Trends Neurosci"},{"key":"1083_CR15","unstructured":"Bates G, Benn C (2002) The polyglutamine diseases. In: Bates G, Harper P and Jones L (eds) Huntington\u2019s disease, Oxford University Press, London, p 429\u2013474"},{"key":"1083_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","volume":"27","author":"MA Hickey","year":"2003","unstructured":"Hickey MA, Chesselet MF (2003) Apoptosis in Huntington\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 27:255\u2013265","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1083_CR17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11068-004-0514-8","volume":"33","author":"NA DiProspero","year":"2004","unstructured":"DiProspero NA, Chen EY, Charles V, Plomann M, Kordower JH, Tagle DA (2004) Early changes in Huntington\u2019s disease patient brains involve alterations in cytoskeletal and synaptic elements. J Neurocytol 33:517\u2013533","journal-title":"J Neurocytol"},{"key":"1083_CR18","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","volume":"131","author":"V Leoni","year":"2008","unstructured":"Leoni V, Mariotti C, Tabrizi SJ, Valenza M, Wild EJ, Henley SM, Hobbs NZ, Mandelli ML, Grisoli M, Bjorkhem I, Cattaneo E, Di Donato S (2008) Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease. Brain 131:2851\u20132859","journal-title":"Brain"},{"key":"1083_CR19","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1101\/gad.1673408","volume":"22","author":"ML Duennwald","year":"2008","unstructured":"Duennwald ML, Lindquist S (2008) Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev 22:3308\u20133319","journal-title":"Genes Dev"},{"key":"1083_CR20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","volume":"26","author":"I Dragatsis","year":"2000","unstructured":"Dragatsis I, Levine MS, Zeitlin S (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet 26:300\u2013306","journal-title":"Nat Genet"},{"key":"1083_CR21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293:493\u2013498","journal-title":"Science"},{"key":"1083_CR22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/6986","volume":"17","author":"M Puttaraju","year":"1999","unstructured":"Puttaraju M, Jamison SF, Mansfield SG, Garcia-Blanco MA, Mitchell LG (1999) Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat Biotechnol 17:246\u2013252","journal-title":"Nat Biotechnol"},{"key":"1083_CR23","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.gt.3301307","volume":"7","author":"SG Mansfield","year":"2000","unstructured":"Mansfield SG, Kole J, Puttaraju M, Yang CC, Garcia-Blanco MA, Cohn JA, Mitchell LG (2000) Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing. Gene Ther 7:1885\u20131895","journal-title":"Gene Ther"},{"key":"1083_CR24","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/104303401750298580","volume":"12","author":"T Kikumori","year":"2001","unstructured":"Kikumori T, Cote GJ, Gagel RF (2001) Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy? Hum Gene Ther 12:1429\u20131441","journal-title":"Hum Gene Ther"},{"key":"1083_CR25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.2001.0426","volume":"4","author":"M Puttaraju","year":"2001","unstructured":"Puttaraju M, DiPasquale J, Baker CC, Mitchell LG, Garcia-Blanco MA (2001) Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing. Mol Ther 4:105\u2013114","journal-title":"Mol Ther"},{"key":"1083_CR26","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1101\/gr.1440703","volume":"13","author":"M Labrador","year":"2003","unstructured":"Labrador M, Corces VG (2003) Extensive exon reshuffling over evolutionary time coupled to trans-splicing in Drosophila. Genome Res 13:2220\u20132228","journal-title":"Genome Res"},{"key":"1083_CR27","doi-asserted-by":"crossref","first-page":"26244","DOI":"10.1074\/jbc.M203513200","volume":"277","author":"G Flouriot","year":"2002","unstructured":"Flouriot G, Brand H, Seraphin B, Gannon F (2002) Natural trans-spliced mRNAs are generated from the human estrogen receptor-alpha (hER alpha) gene. J Biol Chem 277:26244\u201326251","journal-title":"J Biol Chem"},{"key":"1083_CR28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1022983810016","volume":"117","author":"R Dorn","year":"2003","unstructured":"Dorn R, Krauss V (2003) The modifier of mdg4 locus in Drosophila: functional complexity is resolved by trans splicing. Genetica 117:165\u2013177","journal-title":"Genetica"},{"key":"1083_CR29","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1074\/jbc.M109175200","volume":"277","author":"C Finta","year":"2002","unstructured":"Finta C, Zaphiropoulos PG (2002) Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem 277:5882\u20135890","journal-title":"J Biol Chem"},{"key":"1083_CR30","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1073\/pnas.95.21.12185","volume":"95","author":"C Caudevilla","year":"1998","unstructured":"Caudevilla C, Serra D, Miliar A, Codony C, Asins G, Bach M, Hegardt FG (1998) Natural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liver. Proc Natl Acad Sci USA 95:12185\u201312190","journal-title":"Proc Natl Acad Sci USA"},{"key":"1083_CR31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/360692a0","volume":"360","author":"JP Bruzik","year":"1992","unstructured":"Bruzik JP, Maniatis T (1992) Spliced leader RNAs from lower eukaryotes are trans-spliced in mammalian cells. Nature 360:692\u2013695","journal-title":"Nature"},{"key":"1083_CR32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.1156725","volume":"321","author":"H Li","year":"2008","unstructured":"Li H, Wang J, Mor G, Sklar J (2008) A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells. Science 321:1357\u20131361","journal-title":"Science"},{"key":"1083_CR33","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/0008-5472.CAN-08-4926","volume":"69","author":"DS Rickman","year":"2009","unstructured":"Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR, Demichelis F, Rubin MA (2009) SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer Res 69:2734\u20132738","journal-title":"Cancer Res"},{"key":"1083_CR34","doi-asserted-by":"crossref","first-page":"e3468","DOI":"10.1371\/journal.pone.0003468","volume":"3","author":"TH Coady","year":"2008","unstructured":"Coady TH, Baughan TD, Shababi M, Passini MA, Lorson CL (2008) Development of a single vector system that enhances trans-splicing of SMN2 transcripts. PLoS One 3:e3468","journal-title":"PLoS One"},{"key":"1083_CR35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1525-0016(02)00047-3","volume":"7","author":"M Gropp","year":"2003","unstructured":"Gropp M, Itsykson P, Singer O, Ben-Hur T, Reinhartz E, Galun E, Reubinoff BE (2003) Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 7:281\u2013287","journal-title":"Mol Ther"},{"key":"1083_CR36","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia M, Sena-Esteves M, Chase K, Sapp E, Pfister E, Sass M, Yoder J, Reeves P, Pandey RK, Rajeev KG, Manoharan M, Sah DW, Zamore PD, Aronin N (2007) Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci USA 104:17204\u201317209","journal-title":"Proc Natl Acad Sci USA"},{"key":"1083_CR37","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","volume":"105","author":"JL McBride","year":"2008","unstructured":"McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW, Polisky B, Carter BJ, Davidson BL (2008) Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 105:5868\u20135873","journal-title":"Proc Natl Acad Sci USA"},{"key":"1083_CR38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","volume":"65","author":"V Drouet","year":"2009","unstructured":"Drouet V, Perrin V, Hassig R, Dufour N, Auregan G, Alves S, Bonvento G, Brouillet E, Luthi-Carter R, Hantraye P, Deglon N (2009) Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol 65:276\u2013285","journal-title":"Ann Neurol"},{"key":"1083_CR39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.nurt.2008.01.005","volume":"5","author":"H Mochizuki","year":"2008","unstructured":"Mochizuki H, Yasuda T, Mouradian MM (2008) Advances in gene therapy for movement disorders. Neurotherapeutics 5:260\u2013269","journal-title":"Neurotherapeutics"},{"key":"1083_CR40","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/gt.2008.69","volume":"15","author":"O Danos","year":"2008","unstructured":"Danos O (2008) AAV vectors for RNA-based modulation of gene expression. Gene Ther 15:864\u2013869","journal-title":"Gene Ther"},{"key":"1083_CR41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archneurol.2009.180","volume":"66","author":"SQ Harper","year":"2009","unstructured":"Harper SQ (2009) Progress and challenges in RNA interference therapy for Huntington disease. Arch Neurol 66:933\u2013938","journal-title":"Arch Neurol"},{"key":"1083_CR42","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"1083_CR43","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1371\/journal.pgen.0030109","volume":"3","author":"M Wood","year":"2007","unstructured":"Wood M, Yin H, McClorey G (2007) Modulating the expression of disease genes with RNA-based therapy. PLoS Genet 3:e109","journal-title":"PLoS Genet"},{"key":"1083_CR44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-3565(24)38893-7","volume":"295","author":"RJ Boado","year":"2000","unstructured":"Boado RJ, Kazantsev A, Apostol BL, Thompson LM, Pardridge WM (2000) Antisense-mediated down-regulation of the human huntingtin gene. J Pharmacol Exp Ther 295:239\u2013243","journal-title":"J Pharmacol Exp Ther"},{"key":"1083_CR45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mcne.2000.0872","volume":"16","author":"C Nellemann","year":"2000","unstructured":"Nellemann C, Abell K, Norremolle A, Lokkegaard T, Naver B, Ropke C, Rygaard J, Sorensen SA, Hasholt L (2000) Inhibition of Huntington synthesis by antisense oligodeoxynucleotides. Mol Cell Neurosci 16:313\u2013323","journal-title":"Mol Cell Neurosci"},{"key":"1083_CR46","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","volume":"27","author":"J Hu","year":"2009","unstructured":"Hu J, Matsui M, Gagnon KT, Schwartz JC, Gabillet S, Arar K, Wu J, Bezprozvanny I, Corey DR (2009) Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. Nat Biotechnol 27:478\u2013484","journal-title":"Nat Biotechnol"},{"key":"1083_CR47","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ, Davidson BL (2009) Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice. Mol Ther 17:1053\u20131063","journal-title":"Mol Ther"},{"key":"1083_CR48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington\u2019s disease CAG expansion. Nat Genet 17:404\u2013410","journal-title":"Nat Genet"},{"key":"1083_CR49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/hmg\/ddn324","volume":"18","author":"P Dietrich","year":"2009","unstructured":"Dietrich P, Shanmugasundaram R, Shuyu E, Dragatsis I (2009) Congenital hydrocephalus associated with abnormal subcommissural organ in mice lacking huntingtin in Wnt1 cell lineages. Hum Mol Genet 18:142\u2013150","journal-title":"Hum Mol Genet"},{"key":"1083_CR50","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/hum.2007.116","volume":"19","author":"PH Bilsen van","year":"2008","unstructured":"van Bilsen PH, Jaspers L, Lombardi MS, Odekerken JC, Burright EN, Kaemmerer WF (2008) Identification and allele-specific silencing of the mutant huntingtin allele in Huntington\u2019s disease patient-derived fibroblasts. Hum Gene Ther 19:710\u2013719","journal-title":"Hum Gene Ther"},{"key":"1083_CR51","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","volume":"2","author":"DS Schwarz","year":"2006","unstructured":"Schwarz DS, Ding H, Kennington L, Moore JT, Schelter J, Burchard J, Linsley PS, Aronin N, Xu Z, Zamore PD (2006) Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2:e140","journal-title":"PLoS Genet"},{"key":"1083_CR52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","volume":"108","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Engelman J, Friedlander RM (2009) Allele-specific silencing of mutant Huntington\u2019s disease gene. J Neurochem 108:82\u201390","journal-title":"J Neurochem"},{"key":"1083_CR53","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","volume":"19","author":"EL Pfister","year":"2009","unstructured":"Pfister EL, Kennington L, Straubhaar J, Wagh S, Liu W, DiFiglia M, Landwehrmeyer B, Vonsattel JP, Zamore PD, Aronin N (2009) Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington\u2019s disease patients. Curr Biol 19:774\u2013778","journal-title":"Curr Biol"},{"key":"1083_CR54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mcn.2008.09.007","volume":"40","author":"SC Warby","year":"2009","unstructured":"Warby SC, Doty CN, Graham RK, Shively J, Singaraja RR, Hayden MR (2009) Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments. Mol Cell Neurosci 40:121\u2013127","journal-title":"Mol Cell Neurosci"},{"key":"1083_CR55","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll JB, Warby SC, Southwell AL, Doty CN, Greenlee S, Skotte N, Hung G, Bennett CF, Freier SM, Hayden MR (2011) Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin. Mol Ther 19:2178\u20132185","journal-title":"Mol Ther"},{"key":"1083_CR56","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","volume":"19","author":"JL McBride","year":"2011","unstructured":"McBride JL, Pitzer MR, Boudreau RL, Dufour B, Hobbs T, Ojeda SR, Davidson BL (2011) Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease. Mol Ther 19:2152\u20132162","journal-title":"Mol Ther"},{"key":"1083_CR57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neures.2011.05.008","volume":"70","author":"SJ Lee","year":"2011","unstructured":"Lee SJ, Lim HS, Masliah E, Lee HJ (2011) Protein aggregate spreading in neurodegenerative diseases: problems and perspectives. Neurosci Res 70:339\u2013348","journal-title":"Neurosci Res"},{"key":"1083_CR58","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","volume":"70","author":"M Jucker","year":"2011","unstructured":"Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70:532\u2013540","journal-title":"Ann Neurol"},{"key":"1083_CR59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncb1830","volume":"11","author":"PH Ren","year":"2009","unstructured":"Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11:219\u2013225","journal-title":"Nat Cell Biol"},{"key":"1083_CR60","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.gt.3302596","volume":"12","author":"LG Mitchell","year":"2005","unstructured":"Mitchell LG, McGarrity GJ (2005) Gene therapy progress and prospects: reprogramming gene expression by trans-splicing. Gene Ther 12:1477\u20131485","journal-title":"Gene Ther"},{"key":"1083_CR61","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","volume":"219","author":"J Sassone","year":"2009","unstructured":"Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A (2009) Huntington\u2019s disease: the current state of research with peripheral tissues. Exp Neurol 219:385\u2013397","journal-title":"Exp Neurol"},{"key":"1083_CR62","doi-asserted-by":"crossref","first-page":"39935","DOI":"10.1074\/jbc.M004118200","volume":"275","author":"DP Morris","year":"2000","unstructured":"Morris DP, Greenleaf AL (2000) The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II. J Biol Chem 275:39935\u201339943","journal-title":"J Biol Chem"},{"key":"1083_CR63","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1128\/MCB.21.22.7617-7628.2001","volume":"21","author":"AC Goldstrohm","year":"2001","unstructured":"Goldstrohm AC, Albrecht TR, Sune C, Bedford MT, Garcia-Blanco MA (2001) The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol 21:7617\u20137628","journal-title":"Mol Cell Biol"},{"key":"1083_CR64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nbt0102-47","volume":"20","author":"X Liu","year":"2002","unstructured":"Liu X, Jiang Q, Mansfield SG, Puttaraju M, Zhang Y, Zhou W, Cohn JA, Garcia-Blanco MA, Mitchell LG, Engelhardt JF (2002) Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat Biotechnol 20:47\u201352","journal-title":"Nat Biotechnol"},{"key":"1083_CR65","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1089\/hum.2005.16.1116","volume":"16","author":"X Liu","year":"2005","unstructured":"Liu X, Luo M, Zhang LN, Yan Z, Zak R, Ding W, Mansfield SG, Mitchell LG, Engelhardt JF (2005) Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells. Hum Gene Ther 16:1116\u20131123","journal-title":"Hum Gene Ther"},{"key":"1083_CR66","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nm900","volume":"9","author":"H Chao","year":"2003","unstructured":"Chao H, Mansfield SG, Bartel RC, Hiriyanna S, Mitchell LG, Garcia-Blanco MA, Walsh CE (2003) Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat Med 9:1015\u20131019","journal-title":"Nat Med"},{"key":"1083_CR67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/0008-5472.254.65.1","volume":"65","author":"K Nakayama","year":"2005","unstructured":"Nakayama K, Pergolizzi RG, Crystal RG (2005) Gene transfer-mediated pre-mRNA segmental trans-splicing as a strategy to deliver intracellular toxins for cancer therapy. Cancer Res 65:254\u2013263","journal-title":"Cancer Res"},{"key":"1083_CR68","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ymthe.2003.08.022","volume":"8","author":"RG Pergolizzi","year":"2003","unstructured":"Pergolizzi RG, Ropper AE, Dragos R, Reid AC, Nakayama K, Tan Y, Ehteshami JR, Coleman SH, Silver RB, Hackett NR, Menez A, Crystal RG (2003) In vivo trans-splicing of 5\u2032 and 3\u2032 segments of pre-mRNA directed by corresponding DNA sequences delivered by gene transfer. Mol Ther 8:999\u20131008","journal-title":"Mol Ther"},{"key":"1083_CR69","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm1086","volume":"10","author":"M Tahara","year":"2004","unstructured":"Tahara M, Pergolizzi RG, Kobayashi H, Krause A, Luettich K, Lesser ML, Crystal RG (2004) Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency. Nat Med 10:835\u2013841","journal-title":"Nat Med"},{"key":"1083_CR70","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.jid.5701152","volume":"128","author":"V Wally","year":"2008","unstructured":"Wally V, Klausegger A, Koller U, Lochmuller H, Krause S, Wiche G, Mitchell LG, Hintner H, Bauer JW (2008) 5\u2032 trans-splicing repair of the PLEC1 gene. J Invest Dermatol 128:568\u2013574","journal-title":"J Invest Dermatol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-012-1083-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-012-1083-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-012-1083-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T22:33:10Z","timestamp":1743805990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-012-1083-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,20]]},"references-count":70,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1007\/s00018-012-1083-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,20]]}}}